Cosmo & Ferring Pharmaceuticals enter into licensing agreement for CORTIMENT®MMX® (budesonide) in Japan
- by pulseCosmo Pharmaceuticals S.A. (SIX: COPN) announced today that it has signed a licensing agreement with Ferring Pharmaceuticals…
pulseFerring Pharmaceuticals submits variation application to introduce new tailored dosing regimen in the PICOPREP® (sodium picosulfate, magnesium oxide, citric acid) label
- by pulseFerring Pharmaceuticals announced today that it has submitted a variation application in the Mutual Recognition…
pulseFerring receives acceptance of Marketing Authorisation filing from EMA for personalised fertility treatment with REKOVELLE® (follitropin delta)
- by pulseFerring Pharmaceuticals announced today that the filing for the Marketing Authorisation Application for…
pulseFerring Pharmaceuticals acquires global rights to MILPROSA (progesterone vaginal ring)
- by pulseFerring Pharmaceuticals announced today that it has acquired the global rights to MILPROSATM (progesterone vaginal ring) from Teva Women’s…
pulseFerring Pharmaceuticals begins Phase 2b/3 trial of selepressin for treatment of septic shock
- by pulseFerring Pharmaceuticals announced initiation of patient enrollment in a phase 2b/3 clinical trial of selepressin for the treatment of septic shock…
pulse
Archives Press release 2015
Archives Press release 2015